GRIN1 and epilepsy: Novel treatments for epilepsy are also being formulated for nasal administration; siRNA was effectively used to silence the GluN1 gene, which encodes the GluN1 subunit of the AMPA receptor, in the hippocampus to reduce excitatory neurotransmission and epileptic activity.